Beschreibung
Western blot analysis of amyloid-beta 1-40 and 1-42 oligomers grown for 24 hours with and without 20 micromolar curcumin or RuCurcumin, demonstrating reduced oligomer formation with the ruthenium derivative.
Figure 10
Source Paper
Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization.Cite This Figure
![Figure 10: Western blot analysis of amyloid-beta 1-40 and 1-42 oligomers grown for 24 hours with and without 20 micromolar curcumin or RuCurcumin, demonstrating reduced oligomer formation with the ruthenium derivative.]() > Source: Massimiliano Cuccioloni et al. "Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthen." *International journal of molecular sciences*, 2022. PMID: [35955845](https://pubmed.ncbi.nlm.nih.gov/35955845/)
<figure> <img src="" alt="Western blot analysis of amyloid-beta 1-40 and 1-42 oligomers grown for 24 hours with and without 20 micromolar curcumin or RuCurcumin, demonstrating reduced oligomer formation with the ruthenium derivative." /> <figcaption>Figure 10. Western blot analysis of amyloid-beta 1-40 and 1-42 oligomers grown for 24 hours with and without 20 micromolar curcumin or RuCurcumin, demonstrating reduced oligomer formation with the ruthenium derivative.<br> Source: Massimiliano Cuccioloni et al. "Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthen." <em>International journal of molecular sciences</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35955845/">35955845</a></figcaption> </figure>